DeepIntent, Inc.

DeepIntent is a healthcare marketing technology company that operates as a leading demand-side platform (DSP) specifically designed for the healthcare industry. Founded on the principle that advertising can drive better patient outcomes, the company's core mission is to improve health outcomes through the strategic application of advertising, data science, and real-world clinical data. DeepIntent is headquartered in New York, NY, with its main corporate office located at 4 Bryant Park.

The company's platform, powered by its proprietary "Health Intelligence™," offers advanced audience targeting, omnichannel campaign activation, and healthcare-specific measurement capabilities. DeepIntent provides solutions for both Direct-to-Consumer (DTC) and Healthcare Provider (HCP) campaigns, enabling HIPAA-compliant targeting, brand safety, and reach across various channels including CTV, audio, display, and video. Its offerings include tools like MarketMatch™ and DeepIntent Cortex™ for optimizing media buying and proving health outcomes, serving pharmaceutical companies, healthcare brands, and agencies.

In recent developments, DeepIntent launched DeepIntent Cora™ on September 10, 2026, which it describes as the first fully agentic marketing platform for healthcare, designed to transform omnichannel marketing strategies for pharma companies using AI. This follows the June 2026 introduction of Helix AI, another agentic AI platform for healthcare marketers. The company also became the first healthcare DSP to integrate OptimizeRx's EHR network in May 2026. DeepIntent secured a significant strategic investment of $637 million from Vitruvian Partners in September 2025. Chris Paquette serves as the Founder and CEO of DeepIntent.